Asymmetric Transformation ofN-Acetyl-DL-leucine

Effects of acetyl-DL-leucine in vestibular patients: a clinical study following neurotomy and labyrinthectomy.

For 40 years, the amino acid acetyl-DL-leucine (or isoleucine - Tanganil) has been used in clinical practice to reduce imbalance and autonomic manifestations associated with acute vertigo crises. In animal models, acetyl-DL-leucine accelerates vestibular compensation following unilateral labyrinthectomy, and has only minor effects on normal vestibular function. Our work in animal models suggest...

Niemann-Pick type C disease: Effects of a therapy with acetyl-DL-leucine and vestibular function

The hydrolysis of N-benzoyl-DL-tyrosylglycinamide, N-acetyl-L-tyrosylglycinamide, and N-acetyl-DL-tyrosylglycinamide by chymotrypsin.

Contrary to the report of Bergmann and Fruton (1) the L peptide present in aqueous solutions of N-benzoyl-DL-tyrosylglycinamide, prepared by two independent methods, is rapidly hydrolyzed by crystalline chymotrypsin. At 40” and pH 7.8 in a 0.00344 M solution’ of the DL mixture the L component is hydrolyzed as rapidly as in a 0.00172 M solution of the L peptide (Table I). Because of the relative...

Methionine, DL-homocysteine thiolactone and n-acetyl-DL-methionine for ruminants.

Plasma amino acid response of wethers to abomasal infusions of DL-methionine (DLM), DL-homocysteine thiolactone-HCl (HCTL) and N-acetyl-DL-methionine (NAM), in vivo rumen stability of the latter two methionine analogs and preintestinal absorption of HCTL were studied. The daily infusion of 1.06 g of DLM elevated molar percentage of methionine and lysine in plasma'and decreased molar percentage ...

Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial

BACKGROUND Cerebellar ataxia (CA) is a frequent and often disabling condition that impairs motor functioning and impacts on quality of life (QoL). No medication has yet been proven effective for the symptomatic or even causative treatment of hereditary or non-hereditary, non-acquired CA. So far, the only treatment recommendation is physiotherapy. Therefore, new therapeutic options are needed. B...